Total Payments
$6,769
2024 Payments
$1,320
Companies
38
Transactions
327
Medicare Patients
1,217
Medicare Billing
$228,959
Payment Breakdown by Category
Food & Beverage$6,769 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,769 | 327 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,392 | 72 | $0 (2024) |
| Janssen Biotech, Inc. | $634.86 | 23 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $538.69 | 26 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $492.35 | 26 | $0 (2024) |
| PFIZER INC. | $436.49 | 22 | $0 (2024) |
| Lilly USA, LLC | $421.05 | 19 | $0 (2024) |
| Allergan, Inc. | $344.99 | 19 | $0 (2020) |
| Merck Sharp & Dohme LLC | $263.67 | 19 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $251.41 | 13 | $0 (2024) |
| GENZYME CORPORATION | $207.17 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,320 | 46 | Janssen Biotech, Inc. ($182.82) |
| 2023 | $1,357 | 52 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($246.27) |
| 2022 | $808.03 | 40 | ABBVIE INC. ($254.95) |
| 2021 | $543.84 | 28 | AbbVie Inc. ($165.79) |
| 2020 | $282.57 | 16 | AbbVie Inc. ($88.49) |
| 2019 | $900.06 | 56 | AbbVie, Inc. ($231.93) |
| 2018 | $796.24 | 47 | AbbVie, Inc. ($304.12) |
| 2017 | $761.76 | 42 | Allergan Inc. ($237.77) |
All Payment Transactions
327 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: GI | ||||||
| 10/15/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: GI COLON PREP | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Rare Disease | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $122.88 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.85 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/23/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $49.88 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/16/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $24.95 | General |
| Category: GI | ||||||
| 09/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/23/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Immunology | ||||||
| 07/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: IMMUNOLOGY | ||||||
| 07/08/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.97 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 304 | 2,035 | $323,456 | $81,861 |
| 2022 | 7 | 294 | 649 | $147,825 | $50,121 |
| 2021 | 6 | 308 | 577 | $113,582 | $51,974 |
| 2020 | 5 | 311 | 587 | $120,344 | $45,004 |
Total Patients
1,217
Total Services
3,848
Medicare Billing
$228,959
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 11 | 1,450 | $175,450 | $37,911 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 285 | $72,105 | $27,490 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 55 | $18,150 | $7,493 | 41.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 21 | 61 | $26,840 | $3,385 | 12.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 12 | 28 | $17,279 | $3,096 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 24 | $4,488 | $1,593 | 35.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 11 | 27 | $3,713 | $653.67 | 17.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 18 | $1,604 | $196.00 | 12.2% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 31 | 87 | $3,828 | $44.20 | 1.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 158 | 359 | $86,480 | $34,898 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 61 | $9,386 | $4,111 | 43.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 12 | 34 | $15,988 | $3,994 | 25.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 20 | 54 | $22,230 | $3,303 | 14.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 21 | $5,714 | $2,932 | 51.3% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2022 | 12 | 34 | $4,963 | $839.19 | 16.9% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 31 | 86 | $3,064 | $43.68 | 1.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 157 | 358 | $82,340 | $36,287 | 44.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 64 | 95 | $13,300 | $7,107 | 53.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 40 | 45 | $11,430 | $7,071 | 61.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $3,190 | $1,250 | 39.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 21 | 21 | $2,100 | $235.44 | 11.2% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2021 | 15 | 47 | $1,222 | $22.90 | 1.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 184 | 424 | $97,520 | $36,670 | 37.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 70 | 88 | $12,320 | $5,121 | 41.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 30 | 32 | $8,128 | $3,017 | 37.1% |
About Dr. Alan Nelson, M.D
Dr. Alan Nelson, M.D is a Specialist healthcare provider based in Bridgeport, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720006117.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Nelson, M.D has received a total of $6,769 in payments from pharmaceutical and medical device companies, with $1,320 received in 2024. These payments were reported across 327 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,769).
As a Medicare-enrolled provider, Nelson has provided services to 1,217 Medicare beneficiaries, totaling 3,848 services with total Medicare billing of $228,959. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Internal Medicine
- Location Bridgeport, CT
- Active Since 07/17/2006
- Last Updated 12/06/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1720006117
Products in Payments
- STELARA (Biological) $382.67
- TRULANCE (Drug) $357.90
- ENTYVIO (Biological) $352.18
- LINZESS (Drug) $342.36
- XELJANZ (Drug) $340.63
- Humira (Biological) $276.68
- DUPIXENT (Biological) $231.34
- Linzess (Drug) $216.65
- HUMIRA (Biological) $216.14
- SKYRIZI (Biological) $198.07
- RINVOQ (Biological) $190.55
- TREMFYA (Drug) $182.82
- ZENPEP (Drug) $157.09
- OMVOH (Drug) $156.80
- ZEPOSIA (Drug) $154.40
- IQIRVO (Drug) $150.00
- Trulance (Drug) $141.28
- JANUVIA (Drug) $138.70
- XIFAXAN (Drug) $134.45
- TRULICITY (Drug) $129.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Bridgeport
Dr. Benjamin Weisman, M.d, M.D
Specialist — Payments: $5,788
Specialist $5,788
Dr. Shiv Navada, Md, MD
Specialist — Payments: $5,766
Specialist $5,766
Marc Costa, Md, MD
Specialist — Payments: $5,539
Specialist $5,539
Dr. Patrick Mastroianni, M.d, M.D
Specialist — Payments: $335.57
Specialist $335.57
Richard Link, M.d, M.D
Specialist — Payments: $62.21
Specialist $62.21
Zosimo Adefuin, Md, MD
Specialist — Payments: $14.17
Specialist $14.17